Akoya Biosciences CEO and leadership

Q: Who is the CEO of Akoya Biosciences?

The CEO of Akoya Biosciences is Brian McKelligon.

Q: Who is the founder of Akoya Biosciences?

Garry P. Nolan, Matthew M. Winkler, Yury Goltsev and Nikolay Samusik founded Akoya Biosciences.

Zippia score 4.0

Akoya Biosciences CEO and executives

Executive Summary. Based on our data team's research, Brian McKelligon is the Akoya Biosciences's CEO. Akoya Biosciences has 158 employees, of which 24 are in a leadership position.

Here are further demographic highlights of the leadership team:

The Akoya Biosciences executive team is 29% female and 71% male.
69% of the management team is White.
9% of Akoya Biosciences management is Hispanic or Latino.
11% of the management team is Black or African American.

Work at Akoya Biosciences?

Share your experience

Rate Akoya Biosciences' leaders' effectiveness in guiding the company.

Name & TitleBio

Brian McKelligon

Chief Executive Officer

Brian McKelligon is a Chief Executive Officer at Akoya Biosciences Inc and Board Member at Akoya Biosciences Inc and is based in Menlo Park, California. He has worked as Vice President of Business Development at CELLULAR DYNAMICS INTERNATIONAL INC. and Vice President Sales & Support at 10x Genomics Inc.. Brian attended Santa Clara University.

Garry P. Nolan

Board Member

Matthew M. Winkler

Board Member

Yury Goltsev

Co-Founder

Nikolay Samusik

Co-Founder

Clifford C. Hoyt

Vice President

Ehab A. El-Gabry

Chief Medical Officer

Ehab joined Akoya Biosciences as Chief Medical Officer (CMO) in April 2022 to lead the strategy in advancing the use of spatial phenotyping solutions in the clinical setting. Dr. El-Gabry brings a wealth of experiences critical to our vision of advancing spatial phenotyping in precision medicine and cancer care. He is a board-certified pathologist who served as the Senior Medical Director for Roche Tissue Diagnostics Personalized Health Care Solutions (PHCS). He served as Roche Pharma Services Medical Director and provided medical oversight for Roche Digital Solutions, Roche’s portfolio of digital pathology platforms. Dr. El-Gabry has authored over 100 publications and speaks frequently at domestic and international scientific workshops. Ehab completed his preliminary general surgery and pathology residencies at the Cleveland Clinic, Ohio and his fellowship training in breast pathology and cytopathology at the University of Florida, Jacksonville.

Elliot Shelton

Vice President-Product Management

Gavin Gordon

Vice President-Clinical Market Development

Marilee Moy

Chief People Officer

Do you work at Akoya Biosciences?

Does the leadership team provide a clear direction for Akoya Biosciences?

Akoya Biosciences jobs

Akoya Biosciences founders

Name & TitleBio

Garry P. Nolan

Board Member

Matthew M. Winkler

Board Member

Yury Goltsev

Co-Founder

Nikolay Samusik

Co-Founder

Akoya Biosciences board members

Name & TitleBio

Brian McKelligon

Chief Executive Officer

Garry P. Nolan

Board Member

Matthew M. Winkler

Board Member

Yury Goltsev

Co-Founder

Julia Kennedy-Darling

Board Member

Myla P. Lai-Goldman

Board Member

Robert G. Shepler

Chairman

Scott Mendel

Board Member

Thomas A. Raffin

Board Member

Thomas Patrick Schnettler

Board Member

Akoya Biosciences executives FAQs

Who is the CEO of Akoya Biosciences?

Who is the founder of Akoya Biosciences?

Akoya Biosciences highest paying jobs

Companies
California
Menlo Park, CA
Akoya Biosciences
Akoya Biosciences Executives

Updated November 18, 2022

Zippia gives an in-depth look into the details of Akoya Biosciences, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Akoya Biosciences. The employee data is based on information from people who have self-reported their past or current employments at Akoya Biosciences. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Akoya Biosciences. The data presented on this page does not represent the view of Akoya Biosciences and its employees or that of Zippia.

Akoya Biosciences may also be known as or be related to AKOYA BIOSCIENCES, INC., Akoya Biosciences, Akoya Biosciences Inc and Akoya Biosciences, Inc.